Permanent neonatal diabetes caused by an in-frame deletion in the N-terminus of Kir6.2

被引：0
|
作者：
Craig, T. J. [1 ]
Shimomura, K. [1 ]
Flanagan, S. [2 ]
Ellard, S. [2 ]
Hattersley, A. [2 ]
Ashcroft, F. M. [1 ]
机构：
[1] Univ Oxford, Exeter, Devon, England
[2] Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
239
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [31] Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes
    Christophe A. J. Girard
    Kenju Shimomura
    Peter Proks
    Nathan Absalom
    Luis Castano
    Guiomar Perez de Nanclares
    Frances M. Ashcroft
    Pflügers Archiv, 2006, 453 : 323 - 332
  • [32] Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2 -: Patient characteristics and initial response to sulfonylurea therapy
    Sagen, JV
    Ræder, H
    Hathout, E
    Shehadeh, N
    Gudmundsson, K
    Bævre, H
    Abuelo, D
    Phornphutkul, C
    Molnes, J
    Bell, GI
    Gloyn, AL
    Hattersley, AT
    Molven, A
    Sovik, O
    Njolstad, PR
    DIABETES, 2004, 53 (10) : 2713 - 2718
  • [33] Kir6.2 mutations causing neonatal diabetes prevent endocytosis of ATP-sensitive potassium channels
    Mankouri, Jamel
    Taneja, Tarvinder K.
    Smith, Andrew J.
    Ponnambalam, Sreenivasan
    Sivaprasadarao, Asipu
    EMBO JOURNAL, 2006, 25 (17): : 4142 - 4151
  • [34] Amino acid properties may be useful in predicting clinical outcome in patients with Kir6.2 neonatal diabetes
    Fraser, Clementine S.
    Rubio-Cabezas, Oscar
    Littlechild, Jennifer A.
    Ellard, Sian
    Hattersley, Andrew T.
    Flanagan, Sarah E.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 167 (03) : 417 - 421
  • [35] Activating mutations in Kir6.2 and neonatal diabetes - New clinical syndromes, new scientific insights, and new therapy
    Hattersley, AT
    Ashcroft, FM
    DIABETES, 2005, 54 (09) : 2503 - 2513
  • [36] Activating mutations in the gene encoding Kir6.2 alter fetal and postnatal growth and also cause neonatal diabetes
    Slingerland, Annabelle S.
    Hattersley, Andrew T.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (07): : 2782 - 2788
  • [37] Insulin independence with sulphonylurea treatment in a series of patients with permanent neonatal diabetes due to heterozygous activating mutations in the KCNJ11 (Kir6.2) gene
    Pearson, ER
    Flechtner, I
    Ellard, S
    Robert, JJ
    Clark, PM
    Hamilton-Shield, JP
    Polak, M
    Hattersley, AT
    DIABETOLOGIA, 2005, 48 : A113 - A114
  • [38] KCNJ11 (Kir6.2) Gain-of-Function Mutation in Zebrafish Leads to Transient Neonatal Diabetes
    Ikle, Jennifer
    Singareddy, Soma S.
    Tryon, Robert C.
    York, Nathaniel
    Yin, Linlin
    Chen, Wenbiao
    Nichols, Colin
    DIABETES, 2020, 69
  • [39] Kir6.2 mutations associated with neonatal diabetes reduce both ATP-sensitivity and expression of KATP channels
    Lin, CW
    Lin, YW
    Casey, J
    Shyng, SL
    BIOPHYSICAL JOURNAL, 2005, 88 (01) : 181A - 181A
  • [40] Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy
    Proks, Peter
    Girard, Christophe
    Baevre, Halvor
    Njolstad, Pal R.
    Ashcroft, Frances M.
    DIABETES, 2006, 55 (06) : 1731 - 1737
12345